Constrained phytoestrogens and analogues as ERβ selective ligands

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 14, 2003, Pages 2399-2403

  Miller, Chris P ^a   Collini, Michael D ^a   Harris, Heather A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGAND; LUCIFERASE; METALLOTHIONEIN; PHYTOESTROGEN; RALOXIFENE;

ARTICLE; CELL SELECTION; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ASSAY; HUMAN; HUMAN CELL; PROTEIN FUNCTION;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0038003849     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00394-9     Document Type: Article

References (31)

1. (a) Toran-Allerand C.D. J. Steroid Biochem. Mol. Biol. 56:1996;169.
2. (b) Kuiper G.G.J.M., Carlquist M., Gustafsson J.-A. Sci. Med. (Philadelphia). 5:1998;36.
3. (c) Ritzen E.M., Nilsson O., Holst M., Savendahl L., Wroblewski J. J. Steroid Biochem. Mol. Biol. 74:2000;383.
4. (d) Abney T.O. Mol. Andol. 4:1992;281.
5. (a) Francoeur R.T. Marriage Fam. Rev. 18:1993;135.
6. (b) Saunders L. Fam. Plan. Resume. 1:1977;18.
7. (a) Grese T.A., Dodge J.A. Ann. Rep. Med. Chem. 31:1996;181.
8. (b) Grese T.A., Dodge J.A. Curr. Pharm. Des. 4:1998;71.
9. (c) Miller C.P. Curr. Pharm. Des. 8:2002;2089.
10. (a) Doeren M., Schneider H.P.G. Maturitas. 25:1996;99.
11. (b) Tavani A., La Vecchia C. Drugs Aging. 14:1999;347.
12. JAMA. 288:2002;321.
13. Sato M., Glasebrook A.L., Bryant H.U. J. Bone Min. Metab. 12:1994;S9.
14. Clemett D., Spencer C.M. Drugs. 60:2000;370.
15. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Proc. Nat. Acad. Sci. U.S.A. 93:1996;5925.
16. Leygue E., Helmut D., Biao L., Glor C., Watson P.H., Murphy L.C. J. Clin. End. Metab. 83:1998;3754.
17. Pike A.C.W., Brzozowski A.M., Hubbard R.E., Pike A.C.W., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A., Engstrom O., Ljunggren J., Gustafsson J., Carlquist M. EMBO J. 18:1999;4608.
18. Lewandowski S., Kalita K., Kaczmarek L. FEBS Lett. 524:2002;1.
19. (a) Mowa C.N., Iwanaga T. J. Endocrinol. 165:2000;59.
20. (b) Shughrue P.J., Lane M.V., Merchenthaler I. J. Comp. Neurol. 388:1997;507.
21. (c) Bord S., Horner A. J. Clin. Endocrinol. Metab. 86:2001;2309.
22. (d) Saji S., Jensen E.V., Nilsson S., Rylander T., Warner M., Gustafsson J.A. Proc. Nat. Acad. Sci. U.S.A. 97:2000;337.
23. Pettersson K., Delaunay F., Gustafsson J.A. Oncogene. 19:2000;4970.
24. (a) Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., Katzenellenbogen J.A. J. Med. Chem. 44:2001;4230.
25. (b) Schopfer U., Schoeffter P., Bischoff S.F., Nozulak J., Feuerbach D., Floersheim P. J. Med. Chem. 45:2002;1399.
26. Harris H.A., Henderson R.A., Bhat R.A., Komm B.S. Endocrinology. 142:2001;645.
27. Bodine P.V.N., Harris H.A., Komm B.S. Endocrinology. 140:1999;2439.
28. Harris H.A., Bapat A.R., Gonder D.S., Frail D.E. Steroids. 67:2002;379.
29. Tahara S., Ingham J.L., Mizutani J. Agric. Biol. Chem. 49:1985;1775.
30. Tsukayama M., Oda A., Kawamura Y., Nishiuchi M., Yamashita K. Tetrahedron Lett. 42:2001;6163.
31. Collini M.D., Miller C.P. Tetrahedron Lett. 42:2001;8429.